搜索结果31-40 的 807 / ���������������������������op������r���:za33���
The purpose of this study is threefold: the first aim is to use patient-derived fresh tumor tissue to create cell lines and 3D tumor models (i.e. organoids) ...
The purpose of this study is to determine if the drug combination of acalabrutinib, durvalumab, and venetoclax will work to treat Richter's transformation, ...
The purose of this study is to evaluate the effiectiveness, safety, and pharmacokinetics of tirabrutinib monotherapy in patients with relapsed or refractory ...
妙佑医疗国际是美国规模最大、经验最丰富的医疗机构之一,在亚利桑那州、佛罗里达州和明尼苏达州都有院区。医务人员掌握几十种专业技能,齐心协力,确保高品质治疗与成功 ...
显示$起始范围- $结束范围/源自可用$可用医生. 姓氏首字母: R. 是否接收新的患者?
Our AYA Cancer Program provides comprehensive, tailored to people ages 15 to 39 facing the challenges of cancer and addresses the unique needs of each ...
... (R/M) squamous cell carcinoma of the head and neck (SCCHN). A Feasibility ... (r/r B-ALL). Pagination 临床研究. PrevPrevious Page · Go to page 5151 · Go to page ...
Rochester, Minn. The purpose of this study is to determine if the drug combination of acalabrutinib, durvalumab, and venetoclax will work to treat Richter's ...
妙佑医疗国际不为任何公司或产品背书。广告收入为我们的非营利使命提供支持。
浏览妙佑医疗国际出版社提供的畅销书以及书籍和简报的特别优惠。
您的捐赠可以抵税。请您慷慨解囊,和我们一起进行尖端研究和医护,共同推动医学的改变。